Chuck Royce's CRMD Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 441,312 shares of CorMedix Inc. (CRMD) worth $5.13 M, representing 0.05% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in CRMD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's CorMedix (CRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CorMedix (CRMD) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +441,312 | New Buy | 441,312 | $11.63 |
Chuck Royce's CorMedix Investment FAQs
Chuck Royce first purchased CorMedix Inc. (CRMD) in Q3 2025, acquiring 441,312 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held CorMedix Inc. (CRMD) for 1 quarters since Q3 2025.
Chuck Royce's largest addition to CorMedix Inc. (CRMD) was in Q3 2025, adding 441,312 shares worth $5.13 M.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 441,312 shares of CorMedix Inc. (CRMD), valued at approximately $5.13 M.
As of the Q3 2025 filing, CorMedix Inc. (CRMD) represents approximately 0.05% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in CorMedix Inc. (CRMD) was 441,312 shares, as reported at the end of Q3 2025.